Global Recombinant Human Follicle-stimulating Hormone Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Recombinant Human Follicle-stimulating Hormone Market Size was estimated at USD 755.60 million in 2023 and is projected to reach USD 1047.80 million by 2029, exhibiting a CAGR of 5.60% during the forecast period.
This report provides a deep insight into the global Recombinant Human Follicle-stimulating Hormone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant Human Follicle-stimulating Hormone Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant Human Follicle-stimulating Hormone market in any manner.
Global Recombinant Human Follicle-stimulating Hormone Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical
Market Segmentation (by Type)
75IU
150IU
Others
Market Segmentation (by Application)
Infertility Treatment
Assisted Reproductive Technology
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant Human Follicle-stimulating Hormone Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Recombinant Human Follicle-stimulating Hormone Market Size was estimated at USD 755.60 million in 2023 and is projected to reach USD 1047.80 million by 2029, exhibiting a CAGR of 5.60% during the forecast period.
This report provides a deep insight into the global Recombinant Human Follicle-stimulating Hormone market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant Human Follicle-stimulating Hormone Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant Human Follicle-stimulating Hormone market in any manner.
Global Recombinant Human Follicle-stimulating Hormone Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical
Market Segmentation (by Type)
75IU
150IU
Others
Market Segmentation (by Application)
Infertility Treatment
Assisted Reproductive Technology
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Recombinant Human Follicle-stimulating Hormone Market
- Overview of the regional outlook of the Recombinant Human Follicle-stimulating Hormone Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant Human Follicle-stimulating Hormone Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Recombinant Human Follicle-stimulating Hormone
1.2 Key Market Segments
1.2.1 Recombinant Human Follicle-stimulating Hormone Segment by Type
1.2.2 Recombinant Human Follicle-stimulating Hormone Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant Human Follicle-stimulating Hormone Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET COMPETITIVE LANDSCAPE
3.1 Global Recombinant Human Follicle-stimulating Hormone Sales by Manufacturers (2019-2024)
3.2 Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant Human Follicle-stimulating Hormone Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant Human Follicle-stimulating Hormone Sales Sites, Area Served, Product Type
3.6 Recombinant Human Follicle-stimulating Hormone Market Competitive Situation and Trends
3.6.1 Recombinant Human Follicle-stimulating Hormone Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant Human Follicle-stimulating Hormone Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY CHAIN ANALYSIS
4.1 Recombinant Human Follicle-stimulating Hormone Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Type (2019-2024)
6.3 Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant Human Follicle-stimulating Hormone Price by Type (2019-2024)
7 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Human Follicle-stimulating Hormone Market Sales by Application (2019-2024)
7.3 Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant Human Follicle-stimulating Hormone Sales Growth Rate by Application (2019-2024)
8 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET SEGMENTATION BY REGION
8.1 Global Recombinant Human Follicle-stimulating Hormone Sales by Region
8.1.1 Global Recombinant Human Follicle-stimulating Hormone Sales by Region
8.1.2 Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant Human Follicle-stimulating Hormone Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant Human Follicle-stimulating Hormone Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant Human Follicle-stimulating Hormone Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Recombinant Human Follicle-stimulating Hormone Basic Information
9.1.2 Merck Recombinant Human Follicle-stimulating Hormone Product Overview
9.1.3 Merck Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Recombinant Human Follicle-stimulating Hormone SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Ferring
9.2.1 Ferring Recombinant Human Follicle-stimulating Hormone Basic Information
9.2.2 Ferring Recombinant Human Follicle-stimulating Hormone Product Overview
9.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.2.4 Ferring Business Overview
9.2.5 Ferring Recombinant Human Follicle-stimulating Hormone SWOT Analysis
9.2.6 Ferring Recent Developments
9.3 Livzon
9.3.1 Livzon Recombinant Human Follicle-stimulating Hormone Basic Information
9.3.2 Livzon Recombinant Human Follicle-stimulating Hormone Product Overview
9.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.3.4 Livzon Recombinant Human Follicle-stimulating Hormone SWOT Analysis
9.3.5 Livzon Business Overview
9.3.6 Livzon Recent Developments
9.4 Gedeon Richter
9.4.1 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Basic Information
9.4.2 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Overview
9.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.4.4 Gedeon Richter Business Overview
9.4.5 Gedeon Richter Recent Developments
9.5 GenSci
9.5.1 GenSci Recombinant Human Follicle-stimulating Hormone Basic Information
9.5.2 GenSci Recombinant Human Follicle-stimulating Hormone Product Overview
9.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.5.4 GenSci Business Overview
9.5.5 GenSci Recent Developments
9.6 Teva
9.6.1 Teva Recombinant Human Follicle-stimulating Hormone Basic Information
9.6.2 Teva Recombinant Human Follicle-stimulating Hormone Product Overview
9.6.3 Teva Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.6.4 Teva Business Overview
9.6.5 Teva Recent Developments
9.7 ChangChun High and New Technology
9.7.1 ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Basic Information
9.7.2 ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Product Overview
9.7.3 ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.7.4 ChangChun High and New Technology Business Overview
9.7.5 ChangChun High and New Technology Recent Developments
9.8 ABL
9.8.1 ABL Recombinant Human Follicle-stimulating Hormone Basic Information
9.8.2 ABL Recombinant Human Follicle-stimulating Hormone Product Overview
9.8.3 ABL Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.8.4 ABL Business Overview
9.8.5 ABL Recent Developments
9.9 Scripps Laboratories
9.9.1 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Basic Information
9.9.2 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Overview
9.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.9.4 Scripps Laboratories Business Overview
9.9.5 Scripps Laboratories Recent Developments
9.10 Alphamab Oncology
9.10.1 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Basic Information
9.10.2 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Overview
9.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.10.4 Alphamab Oncology Business Overview
9.10.5 Alphamab Oncology Recent Developments
9.11 Hunan Jingfeng Pharmaceutical
9.11.1 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
9.11.2 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
9.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.11.4 Hunan Jingfeng Pharmaceutical Business Overview
9.11.5 Hunan Jingfeng Pharmaceutical Recent Developments
9.12 Qilu Pharmaceutical
9.12.1 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
9.12.2 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
9.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.12.4 Qilu Pharmaceutical Business Overview
9.12.5 Qilu Pharmaceutical Recent Developments
9.13 Beijing SL Pharmaceutical
9.13.1 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
9.13.2 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
9.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.13.4 Beijing SL Pharmaceutical Business Overview
9.13.5 Beijing SL Pharmaceutical Recent Developments
10 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET FORECAST BY REGION
10.1 Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast
10.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Region
10.2.4 South America Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant Human Follicle-stimulating Hormone by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant Human Follicle-stimulating Hormone by Type (2025-2030)
11.1.2 Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant Human Follicle-stimulating Hormone by Type (2025-2030)
11.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) Forecast by Application
11.2.2 Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Recombinant Human Follicle-stimulating Hormone
1.2 Key Market Segments
1.2.1 Recombinant Human Follicle-stimulating Hormone Segment by Type
1.2.2 Recombinant Human Follicle-stimulating Hormone Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Recombinant Human Follicle-stimulating Hormone Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET COMPETITIVE LANDSCAPE
3.1 Global Recombinant Human Follicle-stimulating Hormone Sales by Manufacturers (2019-2024)
3.2 Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share by Manufacturers (2019-2024)
3.3 Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Recombinant Human Follicle-stimulating Hormone Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Recombinant Human Follicle-stimulating Hormone Sales Sites, Area Served, Product Type
3.6 Recombinant Human Follicle-stimulating Hormone Market Competitive Situation and Trends
3.6.1 Recombinant Human Follicle-stimulating Hormone Market Concentration Rate
3.6.2 Global 5 and 10 Largest Recombinant Human Follicle-stimulating Hormone Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE INDUSTRY CHAIN ANALYSIS
4.1 Recombinant Human Follicle-stimulating Hormone Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Type (2019-2024)
6.3 Global Recombinant Human Follicle-stimulating Hormone Market Size Market Share by Type (2019-2024)
6.4 Global Recombinant Human Follicle-stimulating Hormone Price by Type (2019-2024)
7 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant Human Follicle-stimulating Hormone Market Sales by Application (2019-2024)
7.3 Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) by Application (2019-2024)
7.4 Global Recombinant Human Follicle-stimulating Hormone Sales Growth Rate by Application (2019-2024)
8 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET SEGMENTATION BY REGION
8.1 Global Recombinant Human Follicle-stimulating Hormone Sales by Region
8.1.1 Global Recombinant Human Follicle-stimulating Hormone Sales by Region
8.1.2 Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region
8.2 North America
8.2.1 North America Recombinant Human Follicle-stimulating Hormone Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Recombinant Human Follicle-stimulating Hormone Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Recombinant Human Follicle-stimulating Hormone Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Recombinant Human Follicle-stimulating Hormone Basic Information
9.1.2 Merck Recombinant Human Follicle-stimulating Hormone Product Overview
9.1.3 Merck Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Recombinant Human Follicle-stimulating Hormone SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Ferring
9.2.1 Ferring Recombinant Human Follicle-stimulating Hormone Basic Information
9.2.2 Ferring Recombinant Human Follicle-stimulating Hormone Product Overview
9.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.2.4 Ferring Business Overview
9.2.5 Ferring Recombinant Human Follicle-stimulating Hormone SWOT Analysis
9.2.6 Ferring Recent Developments
9.3 Livzon
9.3.1 Livzon Recombinant Human Follicle-stimulating Hormone Basic Information
9.3.2 Livzon Recombinant Human Follicle-stimulating Hormone Product Overview
9.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.3.4 Livzon Recombinant Human Follicle-stimulating Hormone SWOT Analysis
9.3.5 Livzon Business Overview
9.3.6 Livzon Recent Developments
9.4 Gedeon Richter
9.4.1 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Basic Information
9.4.2 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Overview
9.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.4.4 Gedeon Richter Business Overview
9.4.5 Gedeon Richter Recent Developments
9.5 GenSci
9.5.1 GenSci Recombinant Human Follicle-stimulating Hormone Basic Information
9.5.2 GenSci Recombinant Human Follicle-stimulating Hormone Product Overview
9.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.5.4 GenSci Business Overview
9.5.5 GenSci Recent Developments
9.6 Teva
9.6.1 Teva Recombinant Human Follicle-stimulating Hormone Basic Information
9.6.2 Teva Recombinant Human Follicle-stimulating Hormone Product Overview
9.6.3 Teva Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.6.4 Teva Business Overview
9.6.5 Teva Recent Developments
9.7 ChangChun High and New Technology
9.7.1 ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Basic Information
9.7.2 ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Product Overview
9.7.3 ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.7.4 ChangChun High and New Technology Business Overview
9.7.5 ChangChun High and New Technology Recent Developments
9.8 ABL
9.8.1 ABL Recombinant Human Follicle-stimulating Hormone Basic Information
9.8.2 ABL Recombinant Human Follicle-stimulating Hormone Product Overview
9.8.3 ABL Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.8.4 ABL Business Overview
9.8.5 ABL Recent Developments
9.9 Scripps Laboratories
9.9.1 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Basic Information
9.9.2 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Overview
9.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.9.4 Scripps Laboratories Business Overview
9.9.5 Scripps Laboratories Recent Developments
9.10 Alphamab Oncology
9.10.1 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Basic Information
9.10.2 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Overview
9.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.10.4 Alphamab Oncology Business Overview
9.10.5 Alphamab Oncology Recent Developments
9.11 Hunan Jingfeng Pharmaceutical
9.11.1 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
9.11.2 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
9.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.11.4 Hunan Jingfeng Pharmaceutical Business Overview
9.11.5 Hunan Jingfeng Pharmaceutical Recent Developments
9.12 Qilu Pharmaceutical
9.12.1 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
9.12.2 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
9.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.12.4 Qilu Pharmaceutical Business Overview
9.12.5 Qilu Pharmaceutical Recent Developments
9.13 Beijing SL Pharmaceutical
9.13.1 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
9.13.2 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
9.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Market Performance
9.13.4 Beijing SL Pharmaceutical Business Overview
9.13.5 Beijing SL Pharmaceutical Recent Developments
10 RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE MARKET FORECAST BY REGION
10.1 Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast
10.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country
10.2.3 Asia Pacific Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Region
10.2.4 South America Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Recombinant Human Follicle-stimulating Hormone by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Recombinant Human Follicle-stimulating Hormone by Type (2025-2030)
11.1.2 Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Recombinant Human Follicle-stimulating Hormone by Type (2025-2030)
11.2 Global Recombinant Human Follicle-stimulating Hormone Market Forecast by Application (2025-2030)
11.2.1 Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) Forecast by Application
11.2.2 Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant Human Follicle-stimulating Hormone Market Size Comparison by Region (M USD)
Table 5. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Follicle-stimulating Hormone Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2022)
Table 10. Global Market Recombinant Human Follicle-stimulating Hormone Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Recombinant Human Follicle-stimulating Hormone Sales Sites and Area Served
Table 12. Manufacturers Recombinant Human Follicle-stimulating Hormone Product Type
Table 13. Global Recombinant Human Follicle-stimulating Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Recombinant Human Follicle-stimulating Hormone
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant Human Follicle-stimulating Hormone Market Challenges
Table 22. Global Recombinant Human Follicle-stimulating Hormone Sales by Type (Kilotons)
Table 23. Global Recombinant Human Follicle-stimulating Hormone Market Size by Type (M USD)
Table 24. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) by Type (2019-2024)
Table 25. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Type (2019-2024)
Table 26. Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) by Type (2019-2024)
Table 27. Global Recombinant Human Follicle-stimulating Hormone Market Size Share by Type (2019-2024)
Table 28. Global Recombinant Human Follicle-stimulating Hormone Price (USD/Ton) by Type (2019-2024)
Table 29. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) by Application
Table 30. Global Recombinant Human Follicle-stimulating Hormone Market Size by Application
Table 31. Global Recombinant Human Follicle-stimulating Hormone Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application (2019-2024)
Table 33. Global Recombinant Human Follicle-stimulating Hormone Sales by Application (2019-2024) & (M USD)
Table 34. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application (2019-2024)
Table 35. Global Recombinant Human Follicle-stimulating Hormone Sales Growth Rate by Application (2019-2024)
Table 36. Global Recombinant Human Follicle-stimulating Hormone Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region (2019-2024)
Table 38. North America Recombinant Human Follicle-stimulating Hormone Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Recombinant Human Follicle-stimulating Hormone Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Recombinant Human Follicle-stimulating Hormone Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Recombinant Human Follicle-stimulating Hormone Basic Information
Table 44. Merck Recombinant Human Follicle-stimulating Hormone Product Overview
Table 45. Merck Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Recombinant Human Follicle-stimulating Hormone SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Ferring Recombinant Human Follicle-stimulating Hormone Basic Information
Table 50. Ferring Recombinant Human Follicle-stimulating Hormone Product Overview
Table 51. Ferring Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ferring Business Overview
Table 53. Ferring Recombinant Human Follicle-stimulating Hormone SWOT Analysis
Table 54. Ferring Recent Developments
Table 55. Livzon Recombinant Human Follicle-stimulating Hormone Basic Information
Table 56. Livzon Recombinant Human Follicle-stimulating Hormone Product Overview
Table 57. Livzon Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Livzon Recombinant Human Follicle-stimulating Hormone SWOT Analysis
Table 59. Livzon Business Overview
Table 60. Livzon Recent Developments
Table 61. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Basic Information
Table 62. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Overview
Table 63. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Gedeon Richter Business Overview
Table 65. Gedeon Richter Recent Developments
Table 66. GenSci Recombinant Human Follicle-stimulating Hormone Basic Information
Table 67. GenSci Recombinant Human Follicle-stimulating Hormone Product Overview
Table 68. GenSci Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GenSci Business Overview
Table 70. GenSci Recent Developments
Table 71. Teva Recombinant Human Follicle-stimulating Hormone Basic Information
Table 72. Teva Recombinant Human Follicle-stimulating Hormone Product Overview
Table 73. Teva Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Teva Business Overview
Table 75. Teva Recent Developments
Table 76. ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Basic Information
Table 77. ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Product Overview
Table 78. ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. ChangChun High and New Technology Business Overview
Table 80. ChangChun High and New Technology Recent Developments
Table 81. ABL Recombinant Human Follicle-stimulating Hormone Basic Information
Table 82. ABL Recombinant Human Follicle-stimulating Hormone Product Overview
Table 83. ABL Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ABL Business Overview
Table 85. ABL Recent Developments
Table 86. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Basic Information
Table 87. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Overview
Table 88. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Scripps Laboratories Business Overview
Table 90. Scripps Laboratories Recent Developments
Table 91. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Basic Information
Table 92. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Overview
Table 93. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Alphamab Oncology Business Overview
Table 95. Alphamab Oncology Recent Developments
Table 96. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
Table 97. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
Table 98. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hunan Jingfeng Pharmaceutical Business Overview
Table 100. Hunan Jingfeng Pharmaceutical Recent Developments
Table 101. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
Table 102. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
Table 103. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Qilu Pharmaceutical Business Overview
Table 105. Qilu Pharmaceutical Recent Developments
Table 106. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
Table 107. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
Table 108. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Beijing SL Pharmaceutical Business Overview
Table 110. Beijing SL Pharmaceutical Recent Developments
Table 111. Global Recombinant Human Follicle-stimulating Hormone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Recombinant Human Follicle-stimulating Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Recombinant Human Follicle-stimulating Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Recombinant Human Follicle-stimulating Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Recombinant Human Follicle-stimulating Hormone Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Recombinant Human Follicle-stimulating Hormone Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant Human Follicle-stimulating Hormone Market Size Comparison by Region (M USD)
Table 5. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Follicle-stimulating Hormone Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Follicle-stimulating Hormone as of 2022)
Table 10. Global Market Recombinant Human Follicle-stimulating Hormone Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Recombinant Human Follicle-stimulating Hormone Sales Sites and Area Served
Table 12. Manufacturers Recombinant Human Follicle-stimulating Hormone Product Type
Table 13. Global Recombinant Human Follicle-stimulating Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Recombinant Human Follicle-stimulating Hormone
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Recombinant Human Follicle-stimulating Hormone Market Challenges
Table 22. Global Recombinant Human Follicle-stimulating Hormone Sales by Type (Kilotons)
Table 23. Global Recombinant Human Follicle-stimulating Hormone Market Size by Type (M USD)
Table 24. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) by Type (2019-2024)
Table 25. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Type (2019-2024)
Table 26. Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) by Type (2019-2024)
Table 27. Global Recombinant Human Follicle-stimulating Hormone Market Size Share by Type (2019-2024)
Table 28. Global Recombinant Human Follicle-stimulating Hormone Price (USD/Ton) by Type (2019-2024)
Table 29. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) by Application
Table 30. Global Recombinant Human Follicle-stimulating Hormone Market Size by Application
Table 31. Global Recombinant Human Follicle-stimulating Hormone Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application (2019-2024)
Table 33. Global Recombinant Human Follicle-stimulating Hormone Sales by Application (2019-2024) & (M USD)
Table 34. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application (2019-2024)
Table 35. Global Recombinant Human Follicle-stimulating Hormone Sales Growth Rate by Application (2019-2024)
Table 36. Global Recombinant Human Follicle-stimulating Hormone Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region (2019-2024)
Table 38. North America Recombinant Human Follicle-stimulating Hormone Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Recombinant Human Follicle-stimulating Hormone Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Recombinant Human Follicle-stimulating Hormone Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Recombinant Human Follicle-stimulating Hormone Basic Information
Table 44. Merck Recombinant Human Follicle-stimulating Hormone Product Overview
Table 45. Merck Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Recombinant Human Follicle-stimulating Hormone SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Ferring Recombinant Human Follicle-stimulating Hormone Basic Information
Table 50. Ferring Recombinant Human Follicle-stimulating Hormone Product Overview
Table 51. Ferring Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ferring Business Overview
Table 53. Ferring Recombinant Human Follicle-stimulating Hormone SWOT Analysis
Table 54. Ferring Recent Developments
Table 55. Livzon Recombinant Human Follicle-stimulating Hormone Basic Information
Table 56. Livzon Recombinant Human Follicle-stimulating Hormone Product Overview
Table 57. Livzon Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Livzon Recombinant Human Follicle-stimulating Hormone SWOT Analysis
Table 59. Livzon Business Overview
Table 60. Livzon Recent Developments
Table 61. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Basic Information
Table 62. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Overview
Table 63. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Gedeon Richter Business Overview
Table 65. Gedeon Richter Recent Developments
Table 66. GenSci Recombinant Human Follicle-stimulating Hormone Basic Information
Table 67. GenSci Recombinant Human Follicle-stimulating Hormone Product Overview
Table 68. GenSci Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GenSci Business Overview
Table 70. GenSci Recent Developments
Table 71. Teva Recombinant Human Follicle-stimulating Hormone Basic Information
Table 72. Teva Recombinant Human Follicle-stimulating Hormone Product Overview
Table 73. Teva Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Teva Business Overview
Table 75. Teva Recent Developments
Table 76. ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Basic Information
Table 77. ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Product Overview
Table 78. ChangChun High and New Technology Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. ChangChun High and New Technology Business Overview
Table 80. ChangChun High and New Technology Recent Developments
Table 81. ABL Recombinant Human Follicle-stimulating Hormone Basic Information
Table 82. ABL Recombinant Human Follicle-stimulating Hormone Product Overview
Table 83. ABL Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ABL Business Overview
Table 85. ABL Recent Developments
Table 86. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Basic Information
Table 87. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Overview
Table 88. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Scripps Laboratories Business Overview
Table 90. Scripps Laboratories Recent Developments
Table 91. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Basic Information
Table 92. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Overview
Table 93. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Alphamab Oncology Business Overview
Table 95. Alphamab Oncology Recent Developments
Table 96. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
Table 97. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
Table 98. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Hunan Jingfeng Pharmaceutical Business Overview
Table 100. Hunan Jingfeng Pharmaceutical Recent Developments
Table 101. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
Table 102. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
Table 103. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Qilu Pharmaceutical Business Overview
Table 105. Qilu Pharmaceutical Recent Developments
Table 106. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Basic Information
Table 107. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Overview
Table 108. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Beijing SL Pharmaceutical Business Overview
Table 110. Beijing SL Pharmaceutical Recent Developments
Table 111. Global Recombinant Human Follicle-stimulating Hormone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Recombinant Human Follicle-stimulating Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Recombinant Human Follicle-stimulating Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Recombinant Human Follicle-stimulating Hormone Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Recombinant Human Follicle-stimulating Hormone Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Recombinant Human Follicle-stimulating Hormone Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Recombinant Human Follicle-stimulating Hormone
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD), 2019-2030
Figure 5. Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) (2019-2030)
Figure 6. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Human Follicle-stimulating Hormone Market Size by Country (M USD)
Figure 11. Recombinant Human Follicle-stimulating Hormone Sales Share by Manufacturers in 2023
Figure 12. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Manufacturers in 2023
Figure 13. Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Recombinant Human Follicle-stimulating Hormone Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Recombinant Human Follicle-stimulating Hormone Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Recombinant Human Follicle-stimulating Hormone Market Share by Type
Figure 18. Sales Market Share of Recombinant Human Follicle-stimulating Hormone by Type (2019-2024)
Figure 19. Sales Market Share of Recombinant Human Follicle-stimulating Hormone by Type in 2023
Figure 20. Market Size Share of Recombinant Human Follicle-stimulating Hormone by Type (2019-2024)
Figure 21. Market Size Market Share of Recombinant Human Follicle-stimulating Hormone by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application
Figure 24. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application (2019-2024)
Figure 25. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application in 2023
Figure 26. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application (2019-2024)
Figure 27. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application in 2023
Figure 28. Global Recombinant Human Follicle-stimulating Hormone Sales Growth Rate by Application (2019-2024)
Figure 29. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region (2019-2024)
Figure 30. North America Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Recombinant Human Follicle-stimulating Hormone Sales Market Share by Country in 2023
Figure 32. U.S. Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Recombinant Human Follicle-stimulating Hormone Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Recombinant Human Follicle-stimulating Hormone Sales Market Share by Country in 2023
Figure 37. Germany Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region in 2023
Figure 44. China Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (Kilotons)
Figure 50. South America Recombinant Human Follicle-stimulating Hormone Sales Market Share by Country in 2023
Figure 51. Brazil Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Recombinant Human Follicle-stimulating Hormone Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Type (2025-2030)
Figure 65. Global Recombinant Human Follicle-stimulating Hormone Sales Forecast by Application (2025-2030)
Figure 66. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Recombinant Human Follicle-stimulating Hormone
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD), 2019-2030
Figure 5. Global Recombinant Human Follicle-stimulating Hormone Market Size (M USD) (2019-2030)
Figure 6. Global Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant Human Follicle-stimulating Hormone Market Size by Country (M USD)
Figure 11. Recombinant Human Follicle-stimulating Hormone Sales Share by Manufacturers in 2023
Figure 12. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Manufacturers in 2023
Figure 13. Recombinant Human Follicle-stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Recombinant Human Follicle-stimulating Hormone Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Recombinant Human Follicle-stimulating Hormone Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Recombinant Human Follicle-stimulating Hormone Market Share by Type
Figure 18. Sales Market Share of Recombinant Human Follicle-stimulating Hormone by Type (2019-2024)
Figure 19. Sales Market Share of Recombinant Human Follicle-stimulating Hormone by Type in 2023
Figure 20. Market Size Share of Recombinant Human Follicle-stimulating Hormone by Type (2019-2024)
Figure 21. Market Size Market Share of Recombinant Human Follicle-stimulating Hormone by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application
Figure 24. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application (2019-2024)
Figure 25. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Application in 2023
Figure 26. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application (2019-2024)
Figure 27. Global Recombinant Human Follicle-stimulating Hormone Market Share by Application in 2023
Figure 28. Global Recombinant Human Follicle-stimulating Hormone Sales Growth Rate by Application (2019-2024)
Figure 29. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region (2019-2024)
Figure 30. North America Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Recombinant Human Follicle-stimulating Hormone Sales Market Share by Country in 2023
Figure 32. U.S. Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Recombinant Human Follicle-stimulating Hormone Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Recombinant Human Follicle-stimulating Hormone Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Recombinant Human Follicle-stimulating Hormone Sales Market Share by Country in 2023
Figure 37. Germany Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region in 2023
Figure 44. China Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (Kilotons)
Figure 50. South America Recombinant Human Follicle-stimulating Hormone Sales Market Share by Country in 2023
Figure 51. Brazil Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Recombinant Human Follicle-stimulating Hormone Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Recombinant Human Follicle-stimulating Hormone Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Recombinant Human Follicle-stimulating Hormone Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Recombinant Human Follicle-stimulating Hormone Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Recombinant Human Follicle-stimulating Hormone Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Type (2025-2030)
Figure 65. Global Recombinant Human Follicle-stimulating Hormone Sales Forecast by Application (2025-2030)
Figure 66. Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Application (2025-2030)
